In this study, curcumin (CUR) was encapsulated into chitosan (CS) and carboxymethyl cellulose (CMC) microparticles using sodium tripolyphosphate (TPP) as chelator. Here, different concentrations (0.1%, 0.3% and 0.5%) of sodium tripolyphosphate (TPP) were utilised to synthesise microparticles. Microparticles were characterized by Fourier Transform Infra-Red Microscopy (FTIR) and Scanning Electron Microscope (SEM). All the CUR encapsulated microparticles were analysed for their drug encapsulation efficiency and the drug release kinetics. Microparticles were studied for the invitro controlled drug release against Pseudomonas aeruginosa.
INTRODUCTION
The main objective of any nanoparticles/ microparticles based drug carriers is to entrap drug into a biodegradable polymer and to deliver the drug slow and steady [1] [2] [3] [4] . Microparticles with size between 1 and 1000μm have acquired significant interest and can be used in drug delivery. These microparticles are expected to be biocompatible and biodegradable. This property is solely dependent on the nature of the polymers and methods followed [5] [6] [7] [8] . There are several natural biopolymers like chitosan (CS), polyhydroxyalkanoates (PHA), carboxymethyl cellulose (CMC) etc can be used for drug delivery [9] [10] [11] as they are biodegradable and biocompatible 12, 13 . CS, a versatile and second most abundant natural polysaccharide, found to be used in pharmaceutical excipients as it is absolutely biocompatible and biodegradable 14, 15 . It is obtained from partially deacetylated chitin with β-(1-4)-linked 2-amino-2-deoxyb-D-glucopyranose 16, 17 . CS can be used for preparing microparticles by crosslinking the matrix with chemical crosslinking agents such as glutaraldehyde 18 , NaOH 19 , tripolyphosphate 20, 21 etc. Amongst all these, TPP is found to be nontoxic and it interacts with amino groups of CS to form a gel 21 . In acidic environment, amino groups of CS react with an anionic group of other polymers, such as CMC 22, 23 . Thus a biocompatible and biodegradable CMC 24 can be incorporated into CS. CS and CMC microparticles have been well studied for drug delivery 20, [25] [26] [27] [28] . Thus, this study is intended to load curcumin (CUR), a curcuminoid with various bioactivities 29, 30 isolated from rhizome of Curcuma longa L. 31 into TPP chelated CS-CMC microparticles and studied for its controlled drug release invitro against Pseudomonas aeruginosa.
MATERIALS AND METHODS

Materials
The reagents and chemicals used were of analytical grade. Chitosan (C6H11NO4), curcumin and Agar Powder were the make of Sisco Research Laboratories Pvt. Ltd. Acetic acid, Sodium Tripolyphosphate, Carboxymethyl Cellulose and Ethyl Alcohol AR were obtained from Qualigens Fine Chemicals, LOBA Chemie, Micro Fine Chemicals, (India) and Changshu Yangyuan Chemicals respectively. All the chemical preparations were done with Milli-Q water. Preparation of microcarriers using TPP Microparticle production was done by adding oppositely charged crosslinking agents 9, 32 . 100ml of 0.1N acetic acid was added with 0.4% CS. Meanwhile, 0.1%, 0.3% and 0.5% TPP were prepared separately in 50 ml Milli-Q water each. The prepared TPP was taken in a burette and added dropwise to CS solution with continuous stirring at room temperature. 50 ml Milli-Q water was added with 0.15g CMC (0.3%) was taken in a burette and added dropwise to CS chelated with TPP solution and left undisturbed for 2 hours, after that, it was centrifuged at 5000 rpm for 15 min. Supernatant was discarded and the pellet was lyophilised. The lyophilised microparticles synthesised with 0.1%, 0.3% and 0.5% TPP were labelled as CS-CMC-TPP1, CS-CMC-TPP2 and CS-CMC-TPP3 respectively.
Preparation of CUR encapsulated microparticles
Here, 0.05g CUR was dissolved in 50ml ethanol and was added to 100ml of 0.1N acetic acid with 0.4% CS and it DOI number: 10.25258/phyto.v9i2.8151
was chelated with different concentrations of TPP solutions (0.1%, 0.3%, 0.5%) followed with addition of CMC as described above. The curcumin loaded microparticles prepared with 0.1%, 0.3% and 0.5% TPP were labelled as CS-CUR-CMC-TPP1, CS-CUR-CMC-TPP2 and CS-CUR-CMC-TPP3 respectively.
Characterization of microparticles Fourier Transfer Infra-Red Spectroscopy (FTIR) Analysis
All the drug loaded and unloaded microparticles were analysed with transmission mode scan in spectral region of 4000-400 cm -1 in IR Affinity-1s (Shimadzu, Japan) instrument. 
Scanning Electron Microscope (SEM) Analysis
All the microparticles (both the CUR loaded and unloaded) were sprayed and sputter coated with gold for the examination under SEM (JEOL JSM-5610LV).
Evaluation of encapsulation efficiency
Drug encapsulation efficiency (EE) of the CUR loaded microparticles were evaluated by measuring the absorption at 425 nm (λmax of curcumin) at various time intervals of the supernatant liquid (after centrifugation at 5000 rpm for 15 min) using UV Spectrophotometer (Systronics) [33] [34] [35] . At each time interval three samples were taken. Mean value of the samples were calculated and standard error was determined. Graphs were plotted having time interval in x axis and drug encapsulation absorbance in y axis. InVitro drug release kinetics Dialysis membrane technique was used to study drug release kinetics of CUR loaded microparticles 36 . 10 mg of CUR loaded microparticles (i.e. CS-CUR-CMC-TPP1, CS-CUR-CMC-TPP2 and CS-CUR-CMC-TPP3) were separately tied in three dialysis membranes (AV flat width-32.34mm, AV diameter-21.5mm, Capacity approx.-3.63m/cm). They were immersed separately in 50 ml of phosphate buffer solution (PBS) (pH 6.8) and left undisturbed at room temperature. 1 ml (three samples were taken at every time interval) of the released solution was collected at regular time intervals. Absorbance was read at 425 nm in UV visible Spectrophotometer (Systronics) (λmax of CUR). Mean value of the samples were calculated and standard error was determined. Graphs were plotted having time interval in x axis and drug release absorbance in y axis.
InVitro controlled drug release studies Anti-Bacterial activity
To release the CS-CUR-CMC encapsulated drug different solvents are required to break the CS-CMC complex, thus this study was done with four different solvents such as water, ethanol, PBS and acetic acid. InVitro controlled drug release studies and bactericidal activity of CUR loaded microparticles was studied by agar well diffusion method 37, 38 . Pseudomonas aeruginosa was swabbed over
Mueller hinton agar plates, wells were bored using a sterile punching kit. CS-CUR-CMC microparticles were dissolved in different solvents [water, ethanol, PBS (pH 7) and acetic acid (1mg/ml)] and were used to analyse the drug release study. Different concentrations of microparticles (10µg, 20µg, 30µg and 40µg) were poured onto the wells. After 48h the zone of clearance was measured and recorded.
RESULTS AND DISCUSSION
Fourier Transfer Infra-Red Spectroscopy (FTIR) Analysis
The FTIR spectrum of CUR unloaded (Figure 1 a,c,e) and unloaded microparticles (Figure 1b,d ,f) are shown in Figure 1 . The characteristic peaks for amide bonds of CS-CMC-TPP1, CS-CMC-TPP2 and CS-CMC-TPP3 were observed at 1637.56 cm -1 which shows the presence of Nacetylglucosamine 33 . The C-N stretching vibration peaks for CS and CMC were observed at 1377.17 for all carrier samples CS-CMC-TPP1, CS-CMC-TPP2 and CS-CMC-TPP3. TPP characteristic bands at 1206-1215 (P O stretching), 1135-1157 (PO2 groups), 1090-1115 (PO3 groups) and 880 -895 cm −1 (P O P asymmetric 
CS-CMC-TPP2, CS-CUR-CMC-TPP2 CS-CMC-TPP3
, and CS-CUR-CMC-TPP3 respectively which shows the presence of either carbonyl or hydroxyl groups. The C-H respectively (Figure 1 a-f) . C=O stretching was observed at 1654 for CUR loaded microparticles. The characteristic peaks of OCH3 for the presence of CUR were observed at 1153 cm -1 for all the CUR loaded microparticles. C-N stretching was observed at 1377.17 for all microparticles c (Figure 1a-f) . The absorption peaks appeared between 1560 and 1570 cm -1 were due to secondary amide group (N-H bending) 41 . Scanning Electron Microscope (SEM) Analysis SEM analysis of CS-CMC-TPP1, CS-CMC-TPP2 and CS-CMC-TPP3 were fluffy in appearance and smooth irregular in shape (Figure 2 a,c,e,) , whereas the SEM analysis of CS-CUR-CMC-TPP1, CS-CUR-CMC-TPP2 and CS-CUR-CMC-TPP3 were irregular and rod in appearance (Figure 2 b,d,f,) . Our previous work of CS-CMC microparticle production with 0.2%, 0.4% and 0.6% concentrations of TPP was found to produce a fluffy to irregular shape only 20 . Liuyun et al 42 showed the scaffold made of hydroxyl apatite CS-CMC to have irregular porous structure together with good interconnections. Barakat and Almurshedi 43 produced CS microparticles ranged between 675-887µm in diameter. They also found that the viscosity and concentration of CS plays important role in the formation of microparticles. CS/TPP molar ratio and its pH also influence the microparticle formation 20 .
Encapsulation Efficiency
Encapsulation of CUR in all the microparticles was time dependent (Figure 3 ). CS-CMC-TPP3 was showing a faster encapsulation than others. Increased TPP concentration was reported to affect the encapsulation efficiency of the nanoparticles 44 , but in this study is on par with our earlier study 20 where it was found to have good encapsulation at higher concentrations of TPP. InVitro drug release kinetics Drug release kinetics of CUR loaded microparticles was studied at pH 6.8 in phosphate buffer by dialysis membrane technique. The plots of CS-CUR-CMC-TPP1, CS-CUR-CMC-TPP2 and CS-CUR-CMC-TPP3, showed similar kind of drug release kinetics. Higher amount of drug is released in first 40 min and lowered down in next 40min, it maintained a steady state upto 180 min and that of CS-CUR-CMC -TPP3 shows steady release in drug till 120 min and there was a sharp peak at 140min (Figure 4) . Overall drug release kinetic study reveals that CS-CUR CMC-TPP3 holds drug for more time and gradually releases it. Microparticles were getting hydrated slowly in buffer (pH 6.8) and then were diffusing slowly. This is the characteristic of positively charged amines present in CS which allows the acidic media to enter slowly and then release its contents 45 . InVitro controlled release studies No antibacterial activity was observed when water, PBS and ethanol were used as solvent in microparticles chelated with TPP (Table 1, 2, 3 ). This is due to the inability of the solvent to dissolve the CS microparticles. Zone of inhibition was observed when acetic acid was used as solvent to dissolve microparticles (Table 4) , it was found that it dissolves CS and releases the loaded CUR better 20 .
CONCLUSION
In this study, different concentrations of TPP (0.1%, 0.3% and 0.5%) were used to synthesise CS-CMC microparticles. Irregular to rod shaped CS-CMC microparticles were produced. Microparticles were able to encapsulate 0.5% of TPP cross-linked CS-CUR-CMC -TPP3 microparticles which showed faster encapsulation efficiency and slower drug release. Acetic acid alone was found to release the encapsulated CUR to the medium which was evidenced by its antimicrobial activity against Pseudomonas aeruginosa. Thus, an acidic environment favours the drug release.
